These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19772270)

  • 1. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
    Roth DB; Kulkarni KM; Walsman S; Modi A
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
    Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
    Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation.
    Montero JA; Ruiz-Moreno JM; Sanabria MR; Fernandez-Munoz M
    Br J Ophthalmol; 2009 Feb; 93(2):166-70. PubMed ID: 18971240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
    Retina; 2006; 26(6):602-12. PubMed ID: 16829800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
    Sutter FK; Kurz-Levin MM; Scherrer M; Barthelmes D; Fleischhauer JC; Helbig H
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):297-9. PubMed ID: 17458796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
    Jonas JB; Degenring RF; Kreissig I; Friedemann T; Akkoyun I
    Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
    Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
    Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP).
    Sutter FK; Kurz-Levin MM; Fleischhauer J; Bösch MM; Barthelmes D; Helbig H
    Klin Monbl Augenheilkd; 2006 May; 223(5):376-8. PubMed ID: 16705508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
    Ruiz-Moreno JM; Montero JA; Zarbin MA
    Retina; 2007; 27(4):458-61. PubMed ID: 17420698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
    Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
    Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB; Spandau UH; Kamppeter BA; Harder B
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
    Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B
    Ophthalmic Res; 2006; 38(6):324-8. PubMed ID: 17047404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].
    Mozolewska-Piotrowska K; Krzystolik K; Karczewicz D; Drobek-Słowik M; Kubasik-Kładna K
    Klin Oczna; 2011; 113(7-9):233-6. PubMed ID: 22256564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
    Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
    Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients.
    Ito M; Okubo A; Sonoda Y; Yamakiri K; Sakamoto T
    Ophthalmologica; 2006; 220(2):118-24. PubMed ID: 16491035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide].
    Lubiński W; Gosławski W; Mozolewska-Piotrowska K; Szych Z; Karczewicz D
    Ann Acad Med Stetin; 2008; 54(1):22-7; discussion 27. PubMed ID: 19127806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.